BENIGN AND MALIGNANT CHONDROGENIC TUMORS OF BONE
KEY POINTS
- Chondroid lesions are uncommon in the head and neck.
- They do represent a significant percentage of skull base tumors.
- Some controversy still persists with regard to the terminology of chordomas and chondroid variants of chordomas, but this likely has no real clinical relevance with regard to medical decision making or prognosis.
- Pathology of bone lesions should almost always be read together with the imaging findings to produce the best diagnoses and optimize medical decision making.
Tumors of bone may come from one of several cell lines, and more than one line of differentiation may be present in any particular benign or malignant bone tumor. Those arising from the chondrocyte that may be encountered in the head and neck are discussed here. Fibro-osseous, dental-origin, and osteoid tumors, including osteochondromas, and tumors arising from osteoclasts are discussed separately in Chapters 38, 40, 41, and 99. The appearance of various matrices is discussed in Chapter 12.
CHONDROMAS AND CHONDROSARCOMAS
Clinical Perspective and Pathology
Chondromas and chondrosarcomas of the head and neck region are less common than the already rare osteogenic lesions.12 It is probably best to consider any chondroid origin mass a low-grade malignancy with at least the potential for local recurrence.1–4 Chondromas tend to arise from the nasal cartilages (Fig. 39.1), ethmoid bones, skull base (Figs. 39.2–39.4), larynx (Figs. 39.5–39.7), and trachea1,5,6 (Fig. 39.8). Chondrosarcomas seem to most frequently involve the skull base around the petroclival junction and occasionally elsewhere (Fig. 39.9), mandible and, maxilla, but frankly malignant tumors may arise in all sites listed above.7 In addition, the chondroid variant of chordoma can mimic a chondroma on pathologic examination alone.8,9 Peak age incidence is 20 to 40 years of age; however, the age range of occurrence is wide.1